ALLERGY RELIEF-D (CETIRIZINE HCL/PSEUDOEPHEDRINE HCL)
- Allergic conjunctivitis
- Allergic rhinitis
- Cold symptoms
- Nasal congestion
- Allergic conjunctivitis
- Perennial allergic rhinitis
- Rhinorrhea
- Seasonal allergic rhinitis
- Sneezing
- Vasomotor rhinitis
- Zyrtec-d Tablet,extended Release
- Wal-zyr D Tablet,extended Release
- Wal-fex D 12 Hour Tablet,extended Release
- Fexofenadine-pseudoephedrine Er Tablet,ext.release,12 Hr
- Cetirizine-pseudoephedrine Er Tablet,extended Release,12Hr
- Cetirizine-pseudoephedrine Er 12 Hr Tab
- Cetiri-d Tablet,extended Release
- Allergy-congestion Relief-d (fexo) Tablet,extended Release
- Allergy Relief-d Tablet,extended Release
- Allergy Relief-d (fexofenadine) Tablet,extended Release
- Allergy Relief-d (cetirizine) Tablet,extended Release
- Allergy Complete-d Tablet,extended Release
- Aller-tec D Tablet,extended Release
- Allegra-d 12 Hour Tablet,extended Release
- All Day Allergy-d Tablet,extended Release
- By Indication
5 mg-120 mg tablet,extended release
- 1 tablet by oral route every 12 hours
5 mg-120 mg tablet,extended release
- 1 tablet by oral route every 12 hours
60 mg-120 mg tablet,extended release
- 1 tablet by oral route 2 times per day
fexofenadine 60 mg-pseudoephedrine ER 120 mg tablet,ext.release,12 hr
- 1 tablet by oral route 2 times per day
cetirizine 5 mg-pseudoephedrine ER 120 mg tablet,extended release,12hr
- 1 tablet by oral route every 12 hours
cetirizine 5 mg-pseudoephedrine ER 120 mg tablet,extended release,12hr
- 1 tablet by oral route every 12 hours
5 mg-120 mg tablet,extended release
- 1 tablet by oral route every 12 hours
Allergy-Congestion Relief-D (fexo) 60 mg-120 mg tablet,extend release
- 1 tablet by oral route 2 times per day
(cetirizine) 5 mg-120 mg tablet,extended release
- 1 tablet by oral route every 12 hours
(fexofenadine) 60 mg-120 mg tablet,extended release
- 1 tablet by oral route 2 times per day
(cetirizine) 5 mg-120 mg tablet,extended release
- 1 tablet by oral route every 12 hours
5 mg-120 mg tablet,extended release
- 1 tablet by oral route every 12 hours
5 mg-120 mg tablet,extended release
- 1 tablet by oral route every 12 hours
5 mg-120 mg tablet,extended release
- 1 tablet by oral route every 12 hours
60 mg-120 mg tablet,extended release
- 1 tablet by oral route 2 times per day
5 mg-120 mg tablet,extended release
- 1 tablet by oral route every 12 hours
Allergic conjunctivitis
- 1 tablet by oral route 2 times per day
Allergic rhinitis
- 1 tablet by oral route 2 times per day
- 1 tablet by oral route every 12 hours
Perennial allergic rhinitis
- 1 tablet by oral route 2 times per day
- 1 tablet by oral route every 12 hours
Sneezing
- 1 tablet by oral route 2 times per day
- isocarboxazid
- Marplan
- Matulane
- methylene blue (antidote)
- Nardil
- Parnate
- phenelzine
- procarbazine
- tranylcypromine
Contraindicated
- Azilect
- bromocriptine
- cabergoline
- Cafergot
- Cycloset
- D.h.e.45
- dihydroergotamine
- Eldepryl
- ergoloid
- Ergomar
- ergotamine tartrate
- ergotamine-caffeine
- linezolid
- methylergonovine
- Migergot
- Migranal
- Parlodel
- rasagiline
- selegiline HCl
- Zelapar
- Zyvox
Severe
Moderate
- methyldopa
- methyldopa-hydrochlorothiazide
- methyldopate
- reserpine
- Angle-closure glaucoma
- Severe coronary artery disease
- Severe uncontrolled hypertension
- Urinary retention
Contraindicated
- Benign prostatic hyperplasia
- Diabetes mellitus
- Hypertension
- Hyperthyroidism
- Kidney disease with reduction in GFR
Severe
Moderate
- Disease of liver
- Glaucoma
- Kidney disease with reduction in GFR
- Urinary retention
ALLERGY RELIEF-D (CETIRIZINE HCL/PSEUDOEPHEDRINE HCL)
- Allergic conjunctivitis
- Allergic rhinitis
- Cold symptoms
- Nasal congestion
- Allergic conjunctivitis
- Perennial allergic rhinitis
- Rhinorrhea
- Seasonal allergic rhinitis
- Sneezing
- Vasomotor rhinitis
- None
- Drowsy
- Dry nose
- Dry throat
- Headache disorder
- Insomnia
- Xerostomia
More Frequent
Severe
Less Severe
- None
- Agitation
- Anorexia
- Back pain
- Dizziness
- Drowsy
- Dysmenorrhea
- Dyspepsia
- Dysuria
- Fatigue
- General weakness
- Headache disorder
- Insomnia
- Myalgias
- Nausea
- Nervousness
- Pallor
- Pharyngitis
- Sinusitis
- Skin rash
- Tachycardia
- Tremor
- Viral infection
- Vomiting
- Xerostomia
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Acute bacterial otitis media
- Acute generalized exanthematous pustulosis
- Anaphylaxis
- Bronchospastic pulmonary disease
- Cardiac arrhythmia
- Cholestasis
- Disease of liver
- Dyspnea
- Edema
- Hallucinations
- Hepatitis
- Hypersensitivity drug reaction
- Hypertension
- Ischemic colitis
- Palpitations
- Seizure disorder
- Tonic clonic seizure
- Upper respiratory infection
- Urticaria
- Vomiting
Less Severe
- Abdominal pain with cramps
- Acute confusion
- Agitation
- Anorexia
- Blurred vision
- Cardiac arrhythmia
- Constipation
- Cough
- Diarrhea
- Dizziness
- Dyspepsia
- Dysuria
- Earache
- Epistaxis
- Excitement
- Fatigue
- Fever
- Hyperhidrosis
- Increased appetite
- Insomnia
- Nausea
- Nervousness
- Nightmares
- Pain
- Palpitations
- Pruritus of skin
- Skin photosensitivity
- Skin rash
- Symptoms of anxiety
- Tachycardia
- Tinnitus
- Tremor
- Unsteady gait
- Visual changes
- Weight gain
Contraindicated
Pseudoephedrine (SR or High Dose)
Increased sensitivity to side effects. Dose form or strength not appropriate.
- 1 Day – 12 Years
- 1 Increased sensitivity to side effects. Dose form or strength not appropriate.
Severe Precaution
None
Management or Monitoring Precaution
Cetirizine
Safety and efficacy not established in infants age <6 months.
Safety & efficacy in children less than 6 months not established.
Increased incidence of vomiting, diarrhea, somnolence, rhinorrhea age < 5 years.
- 1 Day – 179 Days
- Safety and efficacy not established in infants age <6 months.
- 180 Days – 5 Years
- Safety and efficacy not established in infants age <6 months.
Fexofenadine
Safety and efficacy not established in infants age <6 months.
Safety & efficacy in children less than 6 months not established.
Increased incidence of vomiting, diarrhea, somnolence, rhinorrhea age < 5 years.
- 1 Day – 179 Days
- Safety & efficacy in children less than 6 months not established.
- Increased incidence of vomiting, diarrhea, somnolence, rhinorrhea age < 5 years.
- 180 Days – 5 Years
- Safety & efficacy in children less than 6 months not established.
- Increased incidence of vomiting, diarrhea, somnolence, rhinorrhea age < 5 years.
Cetirizine
- Severity Level:
B
- Additional Notes:
Fexofenadine
- Severity Level:
2
- Additional Notes: Insufficient human data available.
Pseudoephedrine
- Severity Level:
C
- Additional Notes: Fda c w/combo prod; poss risk of gastroschisis/sia with 1st trimester exposure
Contraindicated
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Precaution Exists
Cetirizine
Probably compatible per briggs;May cause sedation in nursing infant.
Insufficient data available; limited data suggest minimal amounts excreted
May decrease milk supply, and cause irritability
General | Excretion Potential | Effect on Infant | Notes |
Evaluate use carefully | Excreted | Not known; no or inclusive data | Probably compatible per briggs;May cause sedation in nursing infant. |
Fexofenadine
Probably compatible per briggs;May cause sedation in nursing infant.
Insufficient data available; limited data suggest minimal amounts excreted
May decrease milk supply, and cause irritability
General | Excretion Potential | Effect on Infant | Notes |
Evaluate use carefully | Excreted | Not known; no or inclusive data | Insufficient data available; limited data suggest minimal amounts excreted |
Pseudoephedrine
Probably compatible per briggs;May cause sedation in nursing infant.
Insufficient data available; limited data suggest minimal amounts excreted
May decrease milk supply, and cause irritability
General | Excretion Potential | Effect on Infant | Notes |
Evaluate use carefully | Excreted | Drug shown to have adverse effect | May decrease milk supply, and cause irritability |
No Known Risk
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Contraindicated
None
Precaution Exists
Cetirizine
Increased risk for neurological side effects. Dosage adjustment may be required.
Decrease daily dose for declining renal function (CLCR<80ml/min).
Cardiovascular-Elderly are more sensitive to tachycardia and hypertensive effects. May exacerbate symptomatic coronary insufficiency. Genitourinary-May cause urinary retention. Neuro/Psych-May worsen cognitive impairment in some elderly with dementia. Insomnia risk.
Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
Increased Risk / Adverse Effects | Y | N | N | Y | N | N |
BEERS: N HEDIS: N STOPP: N
Fexofenadine
Increased risk for neurological side effects. Dosage adjustment may be required.
Decrease daily dose for declining renal function (CLCR<80ml/min).
Cardiovascular-Elderly are more sensitive to tachycardia and hypertensive effects. May exacerbate symptomatic coronary insufficiency. Genitourinary-May cause urinary retention. Neuro/Psych-May worsen cognitive impairment in some elderly with dementia. Insomnia risk.
Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
Increased Risk / Adverse Effects | Y | N | N | N | N | N |
BEERS: N HEDIS: N STOPP: N
Pseudoephedrine
Increased risk for neurological side effects. Dosage adjustment may be required.
Decrease daily dose for declining renal function (CLCR<80ml/min).
Cardiovascular-Elderly are more sensitive to tachycardia and hypertensive effects. May exacerbate symptomatic coronary insufficiency. Genitourinary-May cause urinary retention. Neuro/Psych-May worsen cognitive impairment in some elderly with dementia. Insomnia risk.
Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
Increased Risk / Adverse Effects | Y | N | Y | Y | N | N |
BEERS: N HEDIS: N STOPP: N
No Known Risk
None
- None
Allergic conjunctivitis | |
H10.1 | Acute atopic conjunctivitis |
H10.10 | Acute atopic conjunctivitis, unspecified eye |
H10.11 | Acute atopic conjunctivitis, right eye |
H10.12 | Acute atopic conjunctivitis, left eye |
H10.13 | Acute atopic conjunctivitis, bilateral |
H10.44 | Vernal conjunctivitis |
H10.45 | Other chronic allergic conjunctivitis |
H16.26 | Vernal keratoconjunctivitis, with limbar and corneal involvement |
H16.261 | Vernal keratoconjunctivitis, with limbar and corneal involvement, right eye |
H16.262 | Vernal keratoconjunctivitis, with limbar and corneal involvement, left eye |
H16.263 | Vernal keratoconjunctivitis, with limbar and corneal involvement, bilateral |
H16.269 | Vernal keratoconjunctivitis, with limbar and corneal involvement, unspecified eye |
Allergic rhinitis | |
J30.1 | Allergic rhinitis due to pollen |
J30.2 | Other seasonal allergic rhinitis |
J30.5 | Allergic rhinitis due to food |
J30.8 | Other allergic rhinitis |
J30.81 | Allergic rhinitis due to animal (cat) (dog) hair and dander |
J30.89 | Other allergic rhinitis |
J30.9 | Allergic rhinitis, unspecified |
Cold symptoms | |
J00 | Acute nasopharyngitis [common cold] |
Nasal congestion | |
R09.81 | Nasal congestion |
Perennial allergic rhinitis | |
J31.0 | Chronic rhinitis |
Rhinorrhea | |
R09.82 | Postnasal drip |
Seasonal allergic rhinitis | |
J30.1 | Allergic rhinitis due to pollen |
J30.2 | Other seasonal allergic rhinitis |
Sneezing | |
R06.7 | Sneezing |
Vasomotor rhinitis | |
J30.0 | Vasomotor rhinitis |
0-9 | A-Z |
---|---|
H10.1 | Acute atopic conjunctivitis |
H10.10 | Acute atopic conjunctivitis, unspecified eye |
H10.11 | Acute atopic conjunctivitis, right eye |
H10.12 | Acute atopic conjunctivitis, left eye |
H10.13 | Acute atopic conjunctivitis, bilateral |
H10.44 | Vernal conjunctivitis |
H10.45 | Other chronic allergic conjunctivitis |
H16.26 | Vernal keratoconjunctivitis, with limbar and corneal involvement |
H16.261 | Vernal keratoconjunctivitis, with limbar and corneal involvement, right eye |
H16.262 | Vernal keratoconjunctivitis, with limbar and corneal involvement, left eye |
H16.263 | Vernal keratoconjunctivitis, with limbar and corneal involvement, bilateral |
H16.269 | Vernal keratoconjunctivitis, with limbar and corneal involvement, unspecified eye |
J00 | Acute nasopharyngitis [common cold] |
J30.0 | Vasomotor rhinitis |
J30.1 | Allergic rhinitis due to pollen |
J30.1 | Allergic rhinitis due to pollen |
J30.2 | Other seasonal allergic rhinitis |
J30.2 | Other seasonal allergic rhinitis |
J30.5 | Allergic rhinitis due to food |
J30.8 | Other allergic rhinitis |
J30.81 | Allergic rhinitis due to animal (cat) (dog) hair and dander |
J30.89 | Other allergic rhinitis |
J30.9 | Allergic rhinitis, unspecified |
J31.0 | Chronic rhinitis |
R06.7 | Sneezing |
R09.81 | Nasal congestion |
R09.82 | Postnasal drip |